THERAtRAME

Private

BelgiumHealthcare & Life Scienceshttps://www.theratrame.com/

Last Round

Seed

Sep 5, 2022

Total Funding Raised

$4.46M

Company Overview

THERAtRAME is a biotechnology company that develops first-in-class small molecule therapeutics targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers.

Sector

Healthcare & Life Sciences

Verticals

Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoveryoncology therapeuticstRNA platformbiotechbioinformaticssmall-molecule drugsdrug developmentcancer researchpatient stratificationAI drug discoveryEpiFindpharma partnershipcomputational biologyin silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

THERAtRAME Comparables

Compare THERAtRAME with similar companies based on industry and business-model similarity.

THERAtRAME comparables — related companies by embedding similarity
Company	Similarity	Market Cap
EPICS Therapeutics	31%

View all Comparables

THERAtRAME Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Sep 5, 2022

View all Funding Rounds

THERAtRAME Investors

Notable investors and investment history

THERAtRAME investors
Investor	Rounds
Noshaq	Seed
Gesval	Seed
QBIC III Fund	Seed
Société Régionale d'Investissement de Wallonie	Seed

View all Investors

THERAtRAME Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

THERAtRAME Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about THERAtRAME's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium

Employee Range15

Year Founded2022

Last FundingSep 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?